Global Home Global Home
CANADA

 

A New Era in Anti-Infectives

 

Latest News
..........................................

July 22nd, 2010
Oculus Innovative Sciences Announces Fiscal First Quarter 2011 Financial Results and Corporate Update Release and Conference Call

June 24th, 2010
LifeTech Capital Initiates Research Coverage of Oculus Innovative Sciences

June 3rd, 2010
Oculus Innovative Sciences Reports FY 2010 Financial Results and Reviews Upcoming Microcyn(R) Product Approvals and Introductions

June 2nd, 2010
Oculus Innovative Sciences Launches Microcyn(R) Negative-Pressure Wound Therapy Solution for U.S. Market

May 20th, 2010
Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2010 Financial Results and Corporate Update Release and Conference Call

May 18th, 2010
Oculus Innovative Sciences Updates Business Milestones

April 14th, 2010
Oculus Innovative Sciences to Showcase New Microcyn(R) Wound and Skin Care Products Including Microcyn HydroGel at Symposium on Advanced Wound Care on April 17-20, 2010 in Orlando, Florida

March 25th, 2010
Oculus Innovative Sciences Launches Microcyn(R) Dermatology HydroGel for Relief of Pain and Itch into U.S. Dermatology Healthcare Market

March 11th, 2010
Oculus Innovative Sciences to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference

March 10th, 2010
Oculus Innovative Sciences Receives First FDA Clearance for Microcyn(R)-Based HydroGel for Dermatology Market with Claims Including Reduction of Itch and Pain Relief

More »

..........................................

 

Wound Care, Dermacyn, Microcyn Technology


Oculus Innovative Sciences is pioneering innovative sciences resulting in breakthrough advances in technology. The revolutionary Microcyn® Technology, the company’s first commercialized technology, is now available in various formulations in the Canada.

Dermacyn Wound Care

Dermacyn® Wound Care
Dermacyn® Wound Care is a super-oxidized solution for moistening, lubricating, cleaning and debriding acute and chronic wounds including stage I-IV pressure ulcers, stasis ulcers, diabetic ulcers, post surgical wounds, burns, abrasions and minor irritations of the skin.